Influenza and Other Respiratory Viruses

Scope & Guideline

Innovating strategies for respiratory health.

Introduction

Welcome to your portal for understanding Influenza and Other Respiratory Viruses, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1750-2640
PublisherWILEY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationINFLUENZA OTHER RESP / Influenza Other Respir. Viruses
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Influenza and Other Respiratory Viruses' serves as a pivotal platform for advancing the understanding of respiratory viruses, particularly focusing on influenza and SARS-CoV-2, among others. Its aims encompass a broad range of studies that address the epidemiology, clinical impact, and vaccine effectiveness of respiratory viruses, while also exploring novel diagnostic and therapeutic approaches.
  1. Epidemiology of Respiratory Viruses:
    Research focused on the patterns, causes, and effects of respiratory viruses, including seasonal trends and outbreak dynamics across various populations and geographical locations.
  2. Vaccine Effectiveness and Immunology:
    Investigating the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2, as well as the immunological responses elicited by these vaccines in different demographic groups.
  3. Clinical Outcomes and Disease Burden:
    Studies assessing the clinical implications of infections caused by respiratory viruses, including hospitalization rates, morbidity, mortality, and overall health impact on affected populations.
  4. Diagnostic Methods and Innovations:
    Exploration of novel diagnostic techniques and technologies for the identification and management of respiratory infections, enhancing timely clinical decisions.
  5. Antiviral Treatments and Therapeutic Strategies:
    Research into the efficacy and safety of antiviral medications and other therapeutic interventions aimed at treating infections caused by respiratory viruses.
  6. Surveillance and Public Health:
    Efforts to enhance surveillance systems for respiratory viruses, providing insights into transmission dynamics and informing public health responses.
The journal has shown a dynamic evolution in its research focus, particularly in response to the COVID-19 pandemic. This section outlines the trending and emerging themes that have gained traction in recent publications, highlighting their relevance in current public health discourse.
  1. COVID-19 Vaccine Efficacy and Safety:
    A significant increase in studies evaluating the effectiveness and safety of various COVID-19 vaccines, reflecting ongoing global vaccination efforts and the need for continuous assessment of vaccine performance.
  2. Long COVID and Post-Viral Syndromes:
    Emerging research focusing on the long-term effects of COVID-19, including 'Long COVID' symptoms, is gaining prominence as the medical community seeks to understand and address these complex health issues.
  3. Impact of Non-Pharmaceutical Interventions:
    Studies examining the effects of non-pharmaceutical interventions (NPIs) on respiratory virus transmission patterns, particularly during the COVID-19 pandemic, are increasingly relevant for future public health strategies.
  4. Variants of Concern and Their Epidemiology:
    Research centered on the epidemiology and clinical implications of SARS-CoV-2 variants, particularly Omicron and its sublineages, has surged as understanding these variants is critical for managing future outbreaks.
  5. Artificial Intelligence in Diagnostics:
    The integration of artificial intelligence and machine learning in the diagnosis and management of respiratory viruses, enhancing speed and accuracy in clinical settings, is an emerging trend.

Declining or Waning

While the journal maintains a robust focus on various aspects of respiratory viruses, certain themes have shown a decline in prominence over recent years. This section identifies these waning scopes, reflecting shifts in research priorities and emerging health challenges.
  1. Non-Influenza Respiratory Viruses:
    Research specifically targeting non-influenza respiratory viruses, while still relevant, appears to be receiving comparatively less attention as the focus has shifted towards COVID-19 and its variants.
  2. Historical Analysis of Past Pandemics:
    Studies examining the historical impact of past influenza pandemics are less frequently published, likely overshadowed by contemporary issues related to COVID-19.
  3. Animal Models for Viral Research:
    While still important, the use of animal models in studying respiratory viruses may be declining as more emphasis is placed on human epidemiological studies and clinical trials.
  4. Influenza D Virus Research:
    Research on influenza D virus has waned, possibly due to its relatively low impact on human health compared to other respiratory viruses like influenza A/B and SARS-CoV-2.
  5. Longitudinal Studies of Seasonal Variability:
    Long-term studies tracking seasonal variability of respiratory viruses have decreased, as immediate responses to emerging threats like COVID-19 take precedence.

Similar Journals

Annals of the American Thoracic Society

Transforming respiratory medicine with timely and relevant contributions.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Advances in Respiratory Medicine

Transforming respiratory health through innovative research.
Publisher: MDPIISSN: 2451-4934Frequency: 6 issues/year

Advances in Respiratory Medicine is a distinguished open-access journal published by MDPI, focusing on the latest research and developments in the field of pulmonary and respiratory medicine. Launched in 2015 and operating out of Switzerland, this journal aims to advance scientific discourse and knowledge by providing a platform for researchers, clinicians, and health professionals. With an impressive ISSN of 2451-4934 and an E-ISSN of 2543-6031, it has made its mark in the academic community, reflected by its impact factor and recognition in the Q3 category for Pulmonary and Respiratory Medicine as of 2023. The journal enjoys a ranking of #95 out of 155 in Scopus within its category, providing authors with visibility and the potential for impactful dissemination of their research. Open access since 2022, it ensures that findings are readily available to all, fostering collaboration and innovation across disciplines. With a commitment to quality and rigor, Advances in Respiratory Medicine invites contributions that push the boundaries of existing knowledge, making it an invaluable resource for anyone dedicated to enhancing respiratory health.

Expert Review of Respiratory Medicine

Unraveling Innovations in Respiratory Care
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Exploring the frontiers of pulmonary medicine and patient care.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Egyptian Journal of Chest Diseases and Tuberculosis

Exploring breakthroughs in chest diseases and tuberculosis management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

EUROPEAN RESPIRATORY JOURNAL

Uniting Experts in Respiratory Advancements
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Pulmonology

Leading the way in open-access research for respiratory disorders.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Thoracic Research and Practice

Transforming Knowledge into Practice for Better Lung Health
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

Therapeutic Advances in Respiratory Disease

Advancing Knowledge in Respiratory Health
Publisher: SAGE PUBLICATIONS LTDISSN: 1753-4658Frequency: 1 issue/year

Therapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.

BMC Pulmonary Medicine

Fostering collaboration and knowledge in respiratory care.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.